Actively Recruiting

Age: 18Years +
All Genders
NCT06262295

A Safety and Effectiveness Monitoring in France for AVEIR VR LP and AVEIR AR LP (France LEADLESS)

Led by French Cardiology Society · Updated on 2026-03-09

1000

Participants Needed

1

Research Sites

289 weeks

Total Duration

On this page

Sponsors

F

French Cardiology Society

Lead Sponsor

A

Abbott

Collaborating Sponsor

AI-Summary

What this Trial Is About

Although the idea of a leadless pacemaker was first proposed in the 1970s to eliminate the probes, pockets and connectors required by conventional cardiac procedures and the associated complications, the first devices were not developed until the late 2010s. Leadless pacemakers can also improve patient comfort by replacing surgery with a percutaneous procedure, eliminating the mass and scar visible at the implantation site of a conventional pacemaker, and eliminating the need for activity restrictions to prevent dislodgement after implantation of a conventional lead. This french Registry "France LEADLESS" is a national registry designed to confirm the safety and efficacy of the AVEIR VR LP System in a patient population indicated for the implantation of a VVI(R) pacemaker in France and the AVEIR AR LP System in a population of patients indicated for the implantation of an AAI(R) pacemaker or both systems used in conjunction in a population of patients indicated for the implantation of a DDD(R) pacemaker. This registry will also make it possible to collect the characteristics and indications of patients under normal conditions of use.

CONDITIONS

Official Title

A Safety and Effectiveness Monitoring in France for AVEIR VR LP and AVEIR AR LP (France LEADLESS)

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient has been or will be implanted with device AVEIR VR LP and/or device AVEIR AR LP
  • Patient over 18 years old
  • Patient informed of the nature of the study and agrees to participate
Not Eligible

You will not qualify if you...

  • Patient under 18 years of age
  • Patient refusing to participate in the study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Chu de Grenoble - Hopital Michallon

La Tronche, France, 38700

Actively Recruiting

Loading map...

Research Team

P

Pascal DEFAYE

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here